CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $120,165,474
- in 11 filings, $3.7M under 10b5-1 plans
Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-28 | Rahmer Peter See remarks | Sale | −739 | $11.16 | $8K | 157,504 |
| 2023-04-28 | Catinazzo Thomas Chief Financial Officer | Sale | −863 | $11.16 | $10K | 149,272 |
| 2023-04-28 | Bergstrom Donald A President, R&D | Sale | −1,383 | $11.16 | $15K | 242,701 |
| 2023-04-28 | Adams Brian Chief Legal Officer | Sale | −863 | $11.16 | $10K | 134,882 |
| 2023-03-27 | Rahmer Peter See remarks | Sale | −297 | $15.36 | $5K | 158,243 |
| 2023-03-27 | Catinazzo Thomas Chief Financial Officer | Sale | −347 | $15.36 | $5K | 150,135 |
| 2023-03-27 | Bergstrom Donald A President, R&D | Sale | −763 | $15.36 | $12K | 244,084 |
| 2023-03-27 | Adams Brian Chief Legal Officer | Sale | −347 | $15.36 | $5K | 135,745 |
| 2023-02-09 | Patel Sanjiv President and CEO | Option exercise | +14,000 | $5.04 | $71K | 14,000 |
| 2023-02-09 | Patel Sanjiv President and CEO | Sale | −14,000 | $20.55 | $288K | 0 |
| 2023-02-09 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −14,000 | 568,779 | ||
| 2023-02-08 | Patel Sanjiv President and CEO | Option exercise | +14,000 | $5.04 | $71K | 14,000 |
| 2023-02-08 | Patel Sanjiv President and CEO | Sale | −14,000 | $20.98 | $294K | 0 |
| 2023-02-08 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −14,000 | 582,779 | ||
| 2023-02-07 | Patel Sanjiv President and CEO | Option exercise | +14,000 | $5.04 | $71K | 14,000 |
| 2023-02-07 | Patel Sanjiv President and CEO | Sale | −14,000 | $21.45 | $300K | 0 |
| 2023-02-07 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −14,000 | 596,779 | ||
| 2023-01-30 | Rahmer Peter See remarks | Sale | −740 | $21.56 | $16K | 158,540 |
| 2023-01-30 | Catinazzo Thomas Chief Financial Officer | Sale | −864 | $21.56 | $19K | 150,482 |
| 2023-01-30 | Bergstrom Donald A President, R&D | Sale | −1,429 | $21.56 | $31K | 244,847 |
Page 13 of 17 · 329 trades